Titlebook: Biz Jets; Technology and Marke Almarin Phillips,A. Paul Phillips,Thomas R. Philli Book 1994 Springer Science+Business Media Dordrecht 1994

ORE

HACK

The 1950s: Pressures Build for the Introduction of Business Jets,ngines, equipped to fly day, night and [on] instruments to transport business personnel, prospects, customers, suppliers and friends in connection with the execution of business duties.”. Using that definition, a survey showed that, as of June 30, 1953, “a total of 954 twin-engined business aircraft

Cholecystokinin

傻瓜

Cessna Opens the Lower End of the Market,er of other companies had tried to market a low-priced business jet, and none had come close to success. The MS-760 Paris was available in the U.S. prior to any other business jet, yet it (and subsequent versions of it) found few customers.

勉強

,The “Heavy Iron” Business Jets: Gulfstream, Dassault and Canadair,craft. Grumman’s first planes were the carrier-based, single-seat FF-1, F2F and F3F biplanes. The F4F Wildcat was developed and produced under a 1931 contract with the U.S. Navy. The Wildcat was followed by, among others, the F6F Hellcat (1942), the F7F Tigercat (1945), the F8F Bearcat (1945), the F

硬化

The Market for Mid-Sized Business Jets After 1970, overruns on the total package (fixed price) contract. The AH-56A Cheyenne program ran into similar cost overruns and was threatened with termination in 1969. In the same year, procurement of the C-5 was cut back from 115 to 81 aircraft. The company had similar problems with its missile programs. In

后天習(xí)得

Schumpeterian Rivalry and the Market for Business Jets, rivalry among the suppliers of those aircraft " on "competition from the new [airplane], the new technology, the new [entrant], the new type of organization.". Virtually no attention has been given to the standard "structure-conduct-performance" paradigm of industrial organization economics. In mar

連接

978-3-030-08909-2Springer International Publishing AG, part of Springer Nature 2017

藐視

grovel

Linker Design for Antibody–Drug Conjugates cells, demonstration of the contribution of IL-17 in arthritis would add some new information on the contribution of T cells to the pathogenesis of RA. These issues are important since they may lead to new therapeutic applications. Since this topic has been the subject of a recent review, we will focus on the latest developments [.].